Symbol="GRTS"
AssetType="Common Stock"
Name="Gritstone Oncology Inc"
Description="Gritstone bio, Inc., a clinical-stage biotechnology company, is dedicated to developing tumor-specific cancer immunotherapies to combat various types of cancer and infectious diseases. The company is headquartered in Emeryville, California."
CIK="1656634"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5858 HORTON STREET, SUITE 210, EMERYVILLE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="185829000"
EBITDA="-119511000"
PERatio="None"
PEGRatio="None"
BookValue="1.604"
DividendPerShare="0"
DividendYield="0"
EPS="-1.22"
RevenuePerShareTTM="0.155"
ProfitMargin="0"
OperatingMarginTTM="-8.31"
ReturnOnAssetsTTM="-0.348"
ReturnOnEquityTTM="-0.756"
RevenueTTM="15197000"
GrossProfitTTM="-91458000"
DilutedEPSTTM="-1.22"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.66"
AnalystTargetPrice="8.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="15.92"
PriceToBookRatio="1.59"
EVToRevenue="12.36"
EVToEBITDA="-1.078"
Beta="0.522"
num_52WeekHigh="5.85"
num_52WeekLow="1.64"
num_50DayMovingAverage="2.13"
num_200DayMovingAverage="2.645"
SharesOutstanding="88914000"
DividendDate="None"
ExDividendDate="None"
symbol="GRTS"
open="2.13"
high="2.17"
low="2.01"
price="2.09"
volume="335843.00"
latest_trading_day="2023-07-21"
previous_close="2.10"
change="-0.01"
change_percent="-0.4762%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="94"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="6"
Volume_recent_avg="762171"
Change_recent_avg="-0.01"
Delta_recent_avg="0.18"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-0.53"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_45"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="6"
Aroon_momentum_negative="94"
image_negative_thumbnail_id_1="154"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0022.jpeg"
image_negative_thumbnail_id_2="1095"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0128.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="662"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_positive_thumbnail_id_2="666"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0042.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
